Efficacy of sapropterin dihydrochloride in increasing phenylalanine tolerance in children with phenylketonuria: a phase III, randomized, double-blind, placebo-controlled study
Abstract
Objective To evaluate the ability of sapropterin dihydrochloride (pharmaceutical preparation of tetrahydrobiopterin) to increase phenylalanine (Phe) tolerance while maintaining adequate blood Phe control in 4- to 12-year-old children with phenylketonuria (PKU).Study design This international, double-blind, randomized, placebo-controlled study screened for sapropterin response among 90 enrolled subjects in Part 1. In Part 2, 46 responsive subjects with PKU were randomized (3:1) to sapropterin, 20 mg/kg/d, or placebo for 10 weeks while continuing on a Phe-restricted diet. After 3 weeks, a dietary Phe supplement was added every 2 weeks if Phe control was adequate.Results The mean (+/-SD) Phe supplement tolerated by the sapropterin group had increased significantly from the pretreatment amount (0 mg/kg/d) to 20.9 (+/-15.4) mg/kg/d (P < .001) at the last visit at which subjects had adequate blood Phe control (<360 micromol/L), up to week 10. Over the 10-week period, the placebo group tolerated only an additional 2.9 (+/-4.0) mg/kg/d Phe supplement; the mean difference from the sapropterin group (+/-SE) was 17.7 +/- 4.5 mg/kg/d (P < .001). No severe or serious related adverse events were observed.Conclusions Sapropterin is effective in increasing Phe tolerance while maintaining blood Phe control and has an acceptable safety profile in this population of children with PKU.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Sapropterin is the first non-dietary FDA-approved synthetic BH4 for phenylketonuria and lowers blood phenylalanine by stabilizing and increasing PAH activity.
“Sapropterin (Kuvan) is the first non-dietary, FDA-approved, synthetic form of BH4 for patients with phenylketonuria that is effective in lowering blood Phen levels by stabilizing and increasing PAH activity”
From Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications (2013) · cites this paper as Trefz et al., 2009
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101 · see citing works
The metabolic and molecular bases of inherited disease
Chen, Y.-T. (2001) · Medical Entomology and Zoology · Cited by 6,928 · see citing works
Prefrontal Cortex Cognitive Deficits in Children Treated Early and Continuously for PKU
Diamond, A. D., Prevor, M. B., Callender, G. G., & Druin, D. P. (1997) · Monographs of the Society for Research in Child Development · doi:10.2307/1166208 · Cited by 714 · see citing works
Levy, H. L., Milanowski, A., Chakrapani, A., Cleary, M., Lee, P., Trefz, F. K., Whitley, C. B., Feillet, F., Feigenbaum, A. S. J., Bebchuk, J. D., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61234-3 · Cited by 323 · see citing works
Self-citationTetrahydrobiopterin as an Alternative Treatment for Mild Phenylketonuria
Muntau, A. C., Röschinger, W., Habich, M., Demmelmair, H., Hoffmann, B., Sommerhoff, C. P., & Roscher, A. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021654 · Cited by 309 · see citing works
How practical are recommendations for dietary control in phenylketonuria?
Walter, J., White, F., Hall, S., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09334-0 · Cited by 306 · see citing works
Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency
Kure, S., Hou, D.-C., Ohura, T., Iwamoto, H., Suzuki, S., Sugiyama, N., Sakamoto, O., Fujii, K., Matsubara, Y., & Narisawa, K. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70138-1 · Cited by 301 · see citing works
Panel, N. I. O. H. C. D. (2001) · PEDIATRICS · doi:10.1542/peds.108.4.972 · Cited by 274 · see citing works
Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency
Shintaku, H., Kure, S., Ohura, T., Okano, Y., Ohwada, M., Sugiyama, N., Sakura, N., Yoshida, I., Yoshino, M., Matsubara, Y., et al. (2005) · Zhongguo dangdai erke zazhi · Cited by 254 · see citing works
Neonatal screening in Europe; the situation in 2004
Loeber, J. G. (2007) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-007-0644-5 · Cited by 251 · see citing works
Intelligence and quality of dietary treatment in phenylketonuria.
Smith, I., Beasley, M. G., & Ades, A. E. (1990) · Archives of Disease in Childhood · doi:10.1136/adc.65.5.472 · Cited by 238 · see citing works
Güttler, F. (1980) · PubMed · Cited by 197 · see citing works
Meta-Analysis of Neuropsychological Symptoms of Adolescents and Adults with PKU
Moyle, J. J., Fox, A. M., Arthur, M., Bynevelt, M., & Burnett, J. R. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9021-2 · Cited by 186 · see citing works
Molecular genetics of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency
Zurflüh, M. R., Zschocke, J., Lindner, M. S., et al. (2007) · Human Mutation · doi:10.1002/humu.20637 · Cited by 183 · see citing works
Paine, R. S. (1957) · PEDIATRICS · doi:10.1542/peds.20.2.290 · Cited by 176 · see citing works
Rationale for the German recommendations for phenylalanine level control in phenylketonuria 1997
Burgard, P., Bremer, H. J., Bührdel, P., et al. (1999) · European Journal of Pediatrics · doi:10.1007/s004310051008 · Cited by 147 · see citing works
Brumm, V. L., Azen, C., Moats, R. A., et al. (2004) · Journal of Inherited Metabolic Disease · doi:10.1023/b:boli.0000042985.02049.ff · Cited by 117 · see citing works
Hennermann, J. B., Bührer, C., Blau, N., et al. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2005.05.013 · Cited by 108 · see citing works
Self-citationShintaku, H., Kure, S., Ohura, T., et al. (2003) · Pediatric Research · doi:10.1203/01.pdr.0000111283.91564.7e · Cited by 94 · see citing works
Clinical and nutritional evaluation of phenylketonuric patients on tetrahydrobiopterin monotherapy
Lambruschini, N., Pérez‐Dueñas, B., Vilaseca, M. A., et al. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2005.05.014 · Cited by 94 · see citing works
Prevalence of stimulant use for attentional dysfunction in children with phenylketonuria
Arnold, G., Vladutiu, C. J., Orlowski, C. C., Blakely, E., & DeLuca, J. (2004) · Journal of Inherited Metabolic Disease · doi:10.1023/b:boli.0000028725.37345.62 · Cited by 80 · see citing works
White, D. A., Gragert, M. N., Mandernach, T., Huntington, K., & Steiner, R. D. (2001) · Neuropsychology · doi:10.1037//0894-4105.15.2.221 · Cited by 77 · see citing works
Timing is everything: Executive functions in children exposed to elevated levels of phenylalanine.
Antshel, K. M., & Waisbren, S. E. (2003) · Neuropsychology · doi:10.1037/0894-4105.17.3.458 · Cited by 77 · see citing works
Levy, H. L., Burton, B. K., Cederbaum, S. D., et al. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.09.017 · Cited by 72 · see citing works
Self-citationSeashore, M. R., Wappner, R. S., Cho, S., et al. (1999) · PEDIATRICS · doi:10.1542/peds.104.6.e68 · Cited by 71 · see citing works
Long-term treatment of patients with mild and classical phenylketonuria by tetrahydrobiopterin
Trefz, F. K., Scheible, D., Frauendienst‐Egger, G., et al. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2005.06.026 · Cited by 67 · see citing works
Self-citationSchool Performance in Early and Continuously Treated Phenylketonuria
Gassió, R., Fusté, E., Sala, A. L., et al. (2005) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2005.05.003 · Cited by 65 · see citing works
Bélanger‐Quintana, A., García, M. J., Castro, M., et al. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2005.07.024 · Cited by 63 · see citing works
Azen, C., Koch, R., Friedman, E., Wenz, E., & Fishier, K. (1996) · European Journal of Pediatrics · doi:10.1007/bf03036507 · Cited by 56 · see citing works
White, D. A., Gragert, M. N., Mandernach, T., et al. (2001) · Neuropsychology · doi:10.1037/0894-4105.15.2.221 · Cited by 54 · see citing works
Krause, W. L., Epstein, C. M., Averbook, A., et al. (1986) · Pediatric Research · doi:10.1203/00006450-198611000-00010 · Cited by 53 · see citing works
The tonsil-adenoidectomy enigma
BAKWIN, H. T. (1958) · The Journal of Pediatrics · doi:10.1016/s0022-3476(58)80126-2 · Cited by 48 · see citing works
Phenylketonuria (PKU): screening and management.
Patrias, K., & de la Cruz, F. F. (2002) · PubMed · Cited by 47 · see citing works
Social outcome in treated individuals with inherited metabolic disorders: UK study
Bhat, M. R., Haase, C., & Lee, P. J. (2005) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-005-0159-x · Cited by 25 · see citing works
Comments on diet and compliance in phenylketonuria
Fisch, R. O. (2000) · European Journal of Pediatrics · doi:10.1007/pl00014378 · Cited by 22 · see citing works
Acceptability of a new modular protein substitute for the dietary treatment of phenylketonuria
Rohr, F., Munier, A., & Levy, H. L. (2001) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1012754724708 · Cited by 16 · see citing works
Outcome of early detected and early treated phenylketonuria patients.
Rylance, G. (1989) · PubMed · Cited by 9 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications
Felger, J. C., & Lotrich, F. E. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.060 · Cited by 1,180 · see citing works
The role of dopamine in inflammation-associated depression: mechanisms and therapeutic implications
Felger, J. C. (2016) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2016_13 · Cited by 115 · see citing works
Utz, J. R. J., Lorentz, C. P., Markowitz, D., Rudser, K. D., Diethelm-Okita, B., Erickson, D., & Whitley, C. B. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.10.014 · Cited by 48 · see citing works
Self-citation
- Authors
- Trefz, F. K., Burton, B. K., Longo, N., Casanova, M. M.-P., Gruskin, D. J., Dorenbaum, A., Kakkis, E. D., Crombez, E. A., Grange, D. K., Harmatz, P., Lipson, M. H., Milanowski, A., Randolph, L. M., Vockley, J., Whitley, C. B., Wolff, J. A., Bebchuk, J., Christ-Schmidt, H., & Hennermann, J. B.
- Affiliations
- Kreiskliniken Reutlingen (DE)
- Lurie Children's Hospital (US)
- University of Utah (US)
- Emory University (US)
- BioMarin (United States) (US)
- University of California, Los Angeles (US)
- Washington University in St. Louis (US)
- UCSF Benioff Children's Hospital (US)
- Kaiser Permanente (US)
- Instytut Matki i Dziecka (PL)
- University of Southern California (US)
- University of Pittsburgh (US)
- University of Minnesota (US)
- University of Wisconsin–Madison (US)
- Statistics Collaborative (US)
- Charité – Universitätsmedizin Berlin (DE)
- Corresponding author
- Trefz, Friedrich K.
- ORCID
- Venue
- The Journal of Pediatrics
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 154
- Issue
- 5
- Pages
- 700-707.e1
- ISSN
- 0022-3476 (ISSN-L)
- OpenAlex
- W2037047569
- Cited by
- 196
- References
- 37
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 8 · 2023: 11 · 2022: 7 · 2021: 8 · 2020: 3 · 2019: 13 · 2018: 11 · 2017: 10 · 2016: 5 · 2015: 19 · 2014: 9 · 2013: 11 · 2012: 21
- FWCI
- 14.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Pediatrics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Health Sciences › Medicine › Physiology › Lysosomal Storage Disorders Research
- Keywords
- sapropterin dihydrochloride, phenylketonuria, phenylalanine tolerance, tetrahydrobiopterin, children, phenylalanine-restricted diet, drug safety and efficacy
- MeSH terms
- Algorithms, Biopterins, Child, Child, Preschool, Dose-Response Relationship, Drug, Double-Blind Method, Female, Humans, Male, Phenylalanine, Phenylketonurias, Dietary Supplements
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review